Cargando…
Possible nirmatrelvir/ritonavir-induced bradycardia in a patient with asymptomatic COVID-19
COVID-19 emerged in 2019 and was declared a pandemic by the World Health Organization in March 2020. COVID-19 is highly transmissible and can lead to bilateral pneumonia with severe respiratory failure. COVID-19 has led to more than 6.5 million deaths worldwide. The significant morbidity and mortali...
Autores principales: | DeMarco, Elizabeth, Turnipseed, Matthew, Clarke, Brian, Qadeer, Farhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119650/ https://www.ncbi.nlm.nih.gov/pubmed/37113391 http://dx.doi.org/10.1177/2050313X231168304 |
Ejemplares similares
-
Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022) -
Nirmatrelvir and ritonavir for COVID-19
Publicado: (2022) -
Nirmatrelvir/ritonavir as a possible treatment for Long-COVID
por: Catalán, Ignacio Pérez, et al.
Publicado: (2023) -
Possible medication error risks with nirmatrelvir+ritonavir
Publicado: (2022) -
Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19
por: Lu, Jiayue, et al.
Publicado: (2023)